Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Author Archives: admin

You are here:
  1. Home
  2. Article author admin
Details

Rameda 1Q22 Earnings Release

Earings ReleasesBy adminMay 12, 2022
Details

Standalone financial statements for the period ended 31 March 2022

Standalone Financial StatementsBy adminMay 12, 2022

EGX Disclosure on BOD and shareholding structure

Regulatory DisclosuresBy adminApril 12, 2022
Details

Consolidated financial statements for the period ended 31 March 2022

Consolidated Financial Statements resultsBy adminApril 12, 2022

Disclosure to the Egyptian Stock Exchange regarding the distribution of dividends

Regulatory DisclosuresBy adminApril 7, 2022

Dividend Distribution Form

Regulatory DisclosuresBy adminApril 7, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminMarch 31, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminMarch 30, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminMarch 30, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminMarch 28, 2022
←1
234567891011121314
…1516171819…
2021222324252627282930313233343536
37→

All Rights Reserved © 2024

Go to Top